Literature DB >> 2378792

The effect of clobazam on steady state plasma concentrations of carbamazepine and its metabolites.

J J Muñoz1, R E De Salamanca, C Diaz-Obregón, F L Timoneda.   

Abstract

Steady state metabolite/parent drug plasma ratios were measured in 15 epileptic patients on carbamazepine (CBZ) monotherapy and in seven patients treated with CBZ and clobazam (CLB). CBZ plasma concentrations did not differ between the two groups but patients also treated with CLB exhibited higher concentrations of CBZ-10,11-epoxide (CBZ-E) and trans-10,11-dihydro-10,11-dihydroxy-CBZ (CBZ-T). Ratios between all of the metabolites of CBZ and the parent compound were higher in patients on polytherapy but the ratio between metabolites was not different. CLB comedication causes a moderate increase (about 1.5-fold) in CBZ metabolism, probably by inducing its epoxidation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2378792      PMCID: PMC1380180          DOI: 10.1111/j.1365-2125.1990.tb03699.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  18 in total

1.  Single dose pharmacokinetic study of clobazam in normal volunteers and epileptic patients.

Authors:  S Jawad; A Richens; J Oxley
Journal:  Br J Clin Pharmacol       Date:  1984-12       Impact factor: 4.335

2.  Reduced single-dose clearance of clobazam in elderly men predicts increased multiple-dose accumulation.

Authors:  D J Greenblatt; M Divoll; S K Puri; I Ho; M A Zinny; R I Shader
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

3.  Induction effect of phenobarbital on the carbamazepine to carbamazepine-10, 11-epoxide pathway in rhesus monkeys.

Authors:  I H Patel; P Wedlund; R H Levy
Journal:  J Pharmacol Exp Ther       Date:  1981-06       Impact factor: 4.030

4.  Interdosage fluctuations in plasma carbamazepine concentration determine intermittent side effects.

Authors:  T Tomson
Journal:  Arch Neurol       Date:  1984-08

5.  Carbamazepine 10, 11 epoxide concentrations in epileptics on carbamazepine alone and in combination with other anticonvulsants.

Authors:  M J Brodie; G Forrest; W G Rapeport
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

6.  Effect of valpromide on the pharmacokinetics of carbamazepine-10, 11-epoxide.

Authors:  F Pisani; A Fazio; G Oteri; E Spina; E Perucca; L Bertilsson
Journal:  Br J Clin Pharmacol       Date:  1988-05       Impact factor: 4.335

7.  Effects of cimetidine on carbamazepine auto- and hetero-induction in man.

Authors:  G J Macphee; G G Thompson; G Scobie; E Agnew; B K Park; T Murray; K E McColl; M J Brodie
Journal:  Br J Clin Pharmacol       Date:  1984-09       Impact factor: 4.335

8.  Carbamazepine-10,11-diol steady-state serum levels and renal excretion during carbamazepine therapy in adults and children.

Authors:  B F Bourgeois; N Wad
Journal:  Ther Drug Monit       Date:  1984       Impact factor: 3.681

9.  Analysis of parent drug-metabolite relationship in the presence of an inducer. Application to the carbamazepine-clobazam interaction in normal man.

Authors:  R H Levy; E A Lane; M Guyot; A Brachet-Liermain; B Cenraud; P Loiseau
Journal:  Drug Metab Dispos       Date:  1983 Jul-Aug       Impact factor: 3.922

10.  Individual and combined antiepileptic and neurotoxic activity of carbamazepine and carbamazepine-10,11-epoxide in mice.

Authors:  B F Bourgeois; N Wad
Journal:  J Pharmacol Exp Ther       Date:  1984-11       Impact factor: 4.030

View more
  1 in total

Review 1.  Clinically significant pharmacokinetic drug interactions with carbamazepine. An update.

Authors:  E Spina; F Pisani; E Perucca
Journal:  Clin Pharmacokinet       Date:  1996-09       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.